Package 24979-250-68

Brand: naprelan

Generic: naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 24979-250-68
Digits Only 2497925068
Product NDC 24979-250
Product ID 24979-250_1ae3fb8f-0340-45e5-9f71-fe284c0a6037
Description

75 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-250-68)

Marketing

Marketing Status
Marketed Since 2025-12-31
Brand naprelan
Generic naproxen sodium
Sample Package No

Linked Drug Pages (1)

Naprelan ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1ae3fb8f-0340-45e5-9f71-fe284c0a6037", "openfda": {"upc": ["0324979249018", "0324979251066", "0324979250687"], "unii": ["9TN87S3A3C"], "rxcui": ["1116320", "1116331", "1116339", "1116341", "1116349", "1116351"], "spl_set_id": ["b8a51c9a-488e-4377-a041-436f6a2f8893"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "75 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-250-68)", "package_ndc": "24979-250-68", "marketing_start_date": "20251231"}], "brand_name": "Naprelan", "product_id": "24979-250_1ae3fb8f-0340-45e5-9f71-fe284c0a6037", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "24979-250", "generic_name": "Naproxen Sodium", "labeler_name": "Upsher-Smith Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naprelan", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "500 mg/1"}], "application_number": "NDA020353", "marketing_category": "NDA", "marketing_start_date": "20251231", "listing_expiration_date": "20271231"}